Vaidya Sane Ayurved Laboratories Limited · NSE:MADHAVBAUG

Vaidya Sane Ayurved Laboratories — FY2025 Earnings Presentation

42 slides from Vaidya Sane Ayurved Laboratories's earnings presentation, May 23, 2025

  1. Slide 1: Regulation 30 disclosure cover letter to NSE

    Date: 23rd May 2025 To, Listing Compliance Department, National Stock Exchange of India Limited, Exchange Plaza, Bandra Kurla Complex, Bandra East, Mumbai-400051 NSE Symbol: Madhavbaug Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

  2. Slide 2: Vaidya Sane Ayurved Laboratories Limited Investor Presentation

    Vaidya Sane Ayurved Laboratories Limited Investor Presentation

  3. Slide 3: Disclaimer

    Disclaimer This presentation has been prepared by Vaidya Sane Ayurved Laboratories Limited (the “Company”) solely for information purposes and does not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in conn

  4. Slide 4: Table of contents

    Table of contents 01 02 03 04 05 3

  5. Slide 5: Company Overview

    @ Company Overview —

  6. Slide 6: About Us

    About Us Among leading chains of Cardiac care clinics & State of Art Fully Equipped Hospitals Hospitals ▪ Madhavbaug Hospital Khopoli (NABH Accredited) ▪ Unique medical service institution – focus on ▪ Madhavbaug Hospital Nagpur Traditional Medicine ▪ Madhavbaug Vizag Hospital ▪ Strives to reduce In

  7. Slide 7: Company structure

    Company structure F-Health Accelerators Pvt. Ltd. Cure & Care Primary Care Pvt. Ltd. Easy Ayurveda Pvt. Ltd. 01 (80% Holding) 02 (Raphacure – 17.5% Holding) 03 (15% Holding) ▪ Shareholding Agreement with Dr. ▪ Focus on start-ups that work in the ▪ Shareholding Agreement with Cure and Janardhana V He

  8. Slide 8: Madhavbaug's 360 Degree Ecosystem

    Madhavbaug’s 360 Degree Ecosystem Patients’ vitals monitored on continuous basis through CMS Holistic Treatment and MIB (Madhavbaug Standardized Medicine – Methodology leading to Information Backbone) Pulse prescribed and dispensed objective results Application from clinics Researched diets, tested

  9. Slide 9: Journey so far

    Journey so far ▪ Listing of shares on NSE-Emerge ▪ Khopoli Hospital empanelment with SBI General Insurance ▪ Completion of first production ▪ NABH of Madhavbaug Khopoli Hospital batch of madhavshakti Atta at ▪ Initiated campaign “Fhealth Accelerators” New Factory, of UV Ayurgen ▪ 2006 - 1st Cardiac

  10. Slide 10: Strong & experienced management

    Strong & experienced management Dr. Rohit Sane – Chairman & Managing Director ▪ MBBS (Medicine and Surgery) and fellowship in Cardiac Rehabilitation ▪ More than 20 years of experience in health care consulting ▪ Pioneer in conceptualizing and promoting Ayurveda in healing of chronic heart diseases -

  11. Slide 11: Strong & experienced management

    Strong & experienced management ▪ BAMS, MD (Samhita, Siddhant), PGDEMS and Certified Black belt in Six Sigma Dr. Gurudatta Amin ▪ Affiliated with Madhavbaug since 2007, worked on various levels in medical operations, and Designated as CMO since 2012 Chief Medical Officer ▪ Designed Medical Strategie

  12. Slide 12: Key Strengths

    Key Strengths Strong Research based Treatments & Therapies with papers published and accepted internationally Unique combination of modern healing 01 methods and ancient natural practices 02 Experienced Leadership with able & well- trained team led by Dr. Rohit Madhav Sane Effective, Non- Invasive &

  13. Slide 13: Business Overview

    \ Business Overview

  14. Slide 14: Madhavbaug's Unique Model

    Madhavbaug’s Unique Model Business Clinic Revenue Model Model FY25 Revenue: Rs. 145.55 Cr Hospitals Clinics Services Products ▪ *Revenue : Rs. 23.20 Cr ▪ *Revenue : Rs. 145.55 Cr ▪ *Revenue : Rs. 86.68 Cr ▪ *Revenue : Rs. 58.86 Cr Hospitals, Products, 13.75% 40.44% Clinics, Services, 86.25% 59.56% *

  15. Slide 15: Holistic Treatment Programs

    Holistic Treatment Programs Treatment Programs Secondary Prevention & Rehabilitation Programs: ▪ Heart Failure Reversal Therapy (HFRT) ▪ Plaque Stabilization Therapy (PST) ▪ Ischemia Reversal Programme (IRP) ▪ Diabetic Complication Management (DHCM) ▪ Endo protector ▪ Hypertensive Complication Manag

  16. Slide 16: With innovative reversal therapies

    …With innovative reversal therapies… Heart Disease Diabetes Blood Pressure Obesity Reversal Reversal Management Management ▪ Cardioprotective Therapy ▪ Comprehensive Diabetic Care ▪ Blood Pressure Management ▪ Obesity Management ▪ Ischemic Reversal Program Program Program Program ▪ CAD Management ▪

  17. Slide 17: Pan India Network as on 31st March 2025

    With Pan India Network as on 31st March 2025 States No. of Clinics Jammu and Kashmir 1 Punjab 1 Haryana 1 Uttarakhand 1 Delhi NCR 10 Uttar Pradesh 14 Rajasthan 1 Madhya Pradesh 18 West Bengal 2 Chhattisgarh 1 Gujarat 20 Goa 4 Maharashtra 241 Karnataka 18 Madhavbaug Hospital Khopoli, Total 333 Madhav

  18. Slide 18: State of Art Hospitals – Khopoli, Kondhali & Vizag

    State of Art Hospitals – Khopoli, Kondhali & Vizag Khopoli Hospital (Revenue in Kondhali Hospital (Revenue in Rs. Cr) ▪ Madhavbaug Hospital Khopoli – 1st Hospital in 2006 Rs. Cr) 26.42 7.09 ▪ Madhavbaug Hospital Kondhali, Nagpur – 2nd Hospital in 2012 15.34 ▪ Madhavbaug Vizag Hospital – Vishakhapatn

  19. Slide 19: Multidisciplinary Cardiac Care Clinics

    Multidisciplinary Cardiac Care Clinics 18

  20. Slide 20: Multidisciplinary Cardiac Care Clinics

    Multidisciplinary Cardiac Care Clinics No. of Clinics (Ownershipwise) Average Revenue per Clinic (Rs. in Lacs) Clinic Enterprise Revenue (In Rs. Lacs) No. of Patient - Total Footfall 353 49.19 333 8,02,697 302 9,025 8,564 8,668 277 266 249 6,542 6,344 7,80,462 196 43.21 6,259 5,887 178 42.23 4,909 7

  21. Slide 21: Empanelment with Insurance Companies & TPA's

    Empanelment with Insurance Companies & TPA’s Insurance Companies Third Party Administrators (TPA) More than 30 Insurance companies empaneled with above Third Party Administrators (TPA) each 20

  22. Slide 22: Madhavbaug Power Map

    Madhavbaug Power Map ▪ Medical analytics service built for Madhavbaug Doctors to help them reverse Chronic cardiac disease of their patients effectively - ▪ Union Minister for Road Transport and Highways Nitin Gadkari inaugurated Madhavbaug's Power MAP on 15th January 2022 ▪ Critical Care ▪ Diet Man

  23. Slide 23: MIB Pulse App

    Mib Pulse App - Enable Healthcare reach to lowest strata ▪ It’s a free app which anyone can use from anywhere in case of Medical assistance ▪ App gives you full past history of your health MIB Pulse App (+100K Downloads) ▪ Medical Assistance ✓ Connected Medical Assistance of Doctors to give patients

  24. Slide 24: Research based Disease reversal Diet Kits

    Research based Disease reversal Diet Kits 23

  25. Slide 25: Industry Overview

    @ Industry Overview

  26. Slide 26: India's Non-Communicable Disease (NCD)

    India’s Non – Communicable Disease (NCD) Challenges 66% of all death in India caused by Non – Communicable diseases ▪ Roughly 77 million Diabetes patients in India – Second Highest in the World India estimated to have 44 million Diabetes ▪ Every 2 minutes, someone in India dies from diabetes or its

  27. Slide 27: Higher Stress increasing Diseased population

    Higher Stress increasing Diseased population Middle Class Population ( In million) 800.0 400.0 153.0 Working Age Population of India 2010 2020 2030 (in million) 665.0 Share of Non-communicable diseases 495.0 574.0 – Causes of death, India, 2000-25 463.0 397.0 66.0% 68.0% 70.0% 71.0% 56.0% 62.0% 46.0

  28. Slide 28: Re-emergence of Traditional Medical Care

    Re-emergence of Traditional Medical Care Market size and services offered Notable trends ▪ Indian Ayurvedic Industry expected to reach US$ 9 ▪ Traditional medical sector developing Traditional Knowledge billion by 2022 - Ayurveda medicines - > 90% plant Digital Library to prevent companies from clai

  29. Slide 29: Financial Highlights

    @ Financial Highlights

  30. Slide 30: Management Comments

    Management Comments “During the year, we have registered a Revenue of Rs. 89.85 crore. EBITDA and PAT were Rs. 13.50 crore and 7.15 crore. We are pleased to announce the on boarding of Sonu Sood as our brand ambassador, with campaign rollouts beginning April 8th. This move has already begun enhancin

  31. Slide 31: Madhavbaug Welcomes Sonu Sood as Official Brand Ambassador

    Madhavbaug Welcomes Sonu Sood as Official Brand Ambassador 30

  32. Slide 32: First Hospital in Gujarat

    Madhavbaug Expands Holistic Healthcare with First Hospital in Gujarat ▪ Opening of its first hospital in Gujarat and fourth hospital overall. The newly launched 35-bed facility, situated in Ankodiya village, Vadodara, spans 8 acres and is dedicated to providing advanced holistic treatments for cardi

  33. Slide 33: Consolidated Half Yearly Financial Highlights

    Consolidated Half Yearly Financial Highlights Revenue (Rs. Cr) 53.58 51.10 48.23 48.05 45.59 41.80 H1 FY23 H2 FY23 H1 FY24 H2 FY24 H1 FY25 H2 FY25 EBITDA* (Rs. Cr) PAT (Rs. Cr) 10 20% 7 12.05% 14% 16.11% 6 12% 8 13.79% 15% 5 9.02% 10% 6 4 8% 9.15% 6.00% 10% 4 6.88% 3 2.30% 6% 5.25% 3.77% 3.91% 1.69%

  34. Slide 34: Consolidated Financial Highlights – Half Yearly

    Consolidated Financial Highlights – Half Yearly Rs. Crore H2 FY25 H2 FY24 Y-o-Y (%) H1 FY25 Income from Operations 48.05 48.23 41.80 Other Operating Income 0.00 0.00 0.00 ▪ Revenue from operations for H2 FY25 is Total Income 48.05 48.23 (0.38%) 41.80 Raw Materials 7.54 10.77 9.21 48.05 Crs as agains

  35. Slide 35: Consolidated Financial Highlights – Yearly

    Consolidated Financial Highlights – Yearly Rs. Crore FY25 FY24 Y-o-Y (%) Income from Operations 89.85 99.33 ▪ Revenue from operations for FY25 is Other Operating Income 0.00 0.00 89.85 Crs as against Rs. 99.33 Crs in FY24, Total Income 89.85 99.33 (9.55%) YoY decrease of 9.55% - reduction in total R

  36. Slide 36: Annual Financial Highlights

    Annual Financial Highlights Enterprise Collection (Rs. Cr) Revenue (Rs. Cr) VSAL Clinics & OPD and Mini Clinics Khopoli Hospital Kondhali Hospital Vizag Hospital 99.17 99.33 89.85 157.95 149.00 145.55 74.71 114.70 52.27 19.00 23.00 26.42 15.34 5.00 0.00 7.00 0.00 7.09 0.08 6.82 1.04 FY22 FY23 FY24 F

  37. Slide 37: Balance Sheet as on 31st March 2025

    Balance Sheet as on 31st March 2025 As on 31st As on 31st As on 31st As on 31st Rs. Crore Rs. Crore Mar’ 25 Mar’ 24 Mar’ 25 Mar’ 24 Shareholder’s Funds 62.54 55.60 Non-current assets 46.42 38.36 Share capital 10.52 10.52 Property, Plant & Equipment 21.45 21.27 Other Equity 52.02 31.66 Tangible asset

  38. Slide 38: Key Balance Sheet Ratios

    Key Balance Sheet Ratios RoE(%) RoA(%) 8.80% 9.3% 11.94% 11.41% 6.94% 9.67% 4.02% 3.60% 1.52% 2.87% FY21 FY22* FY23 FY24 FY25 FY21 FY22* FY23 FY24 FY25 RoCE(%) 16.95% 19.4% 17.76% 15.44% 5.63% FY21 FY22* FY23 FY24 FY25 * IPO in FY22 to raise Rs. 20.23 crs RoE = Net Profit/Net Worth | RoA = Net Profi

  39. Slide 39: Way Ahead

    @ Way Ahead

  40. Slide 40: Way Ahead

    Way Ahead Scalable and Standardized Clinic Design ▪ Clinic-based health care delivery model along with tele-medicine - low capex requirement and easy accessibility Strengthening and Expanding Clinic and Hospital Network ▪ Strategic locations in Maharashtra; expand Clinic Network in Madhya Pradesh, U

  41. Slide 41: Madhavbaug's Mission 2028

    Madhavbaug’s Mission 2028 “By 2028, Over 5 Crore People in India will be directly under Madhavbaug’s Care” .. 01 02 03 04 Save My Heart – App Madhavbaug Associate Clinics & Hospitals OPD Purported for preventation 1000 Associate Doctors Expansion of Khopoli Existing network of 50 of heart disease as

  42. Slide 42: Thank You

    Thank You For further information, please contact: Ms. Sapna Vaishnav Vaidya Sane Ayurved Laboratories Ltd Tel: +91 7400192238 Email: cs@Madhavbaug.com Website: www.madhavbaug.org Mr. Amit Sharma / Mr. Rupesh Rege AdfactorsPR Pvt. Ltd. Tel: +91 98677 26686 /+91 9594918891 Email: amit.sharma@adfactor

Vaidya Sane Ayurved Laboratories — FY2025 Earnings Presentation on 6ix